Our Services –
Inhalation product testing
Inhalation Product Testing Services
Inhalation products, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers, are used to treat respiratory conditions and lung diseases. The efficacy and safety of these products depend on precise formulation and rigorous testing. CEMAS is a GxP CRO that provides inhalation product testing services, to help ensure your inhalation products meet the highest standards, from early-stage development through to regulatory submission and post-market surveillance.
Need help or have an enquiry?
Explore our Inhalation Product Testing Capabilities:
- Aerodynamic Particle Size Distribution (APSD) and Particle Size Distribution (PSD) for effective delivery of aerosol
- Delivered Dose Uniformity (DDU) to ensure consistency of delivered dose
- Spray Pattern and Plume Geometry to ensure consistent delivery and proper dispersion of the medication
- Emitted Dose to quantify the amount of drug delivered in each actuation
- Stability Testing
- Foreign particle testing
- Method development and validation
Why choose CEMAS?
Science
Our scientists and study directors bring decades of experience and expertise
Compliance
GLP, GCP and GMP compliance to ensure that your regulatory needs are met
Delivery
Flexibility and responsiveness to your requirements, to provide quality data on time
Reliability
Quality and delivery are at the heart of all we do
